Navigation Links
Failure of heart drug offers lessons for drug industry

Madison, Wis. - Pfizer spent about $800 million to develop torcetrapib, a heart drug that seemed like a blockbuster until people began to die in clinical trials. Hours after learning the drug was irreversibly flawed, the company called a halt to further trials, a decision that sent its stock downward and put thousands of job......

Full article >>> elatively few useful drugs.

Tufts luck

Consider a recent study by Tufts University, which examined the cost of producing biotechnology drugs. Unlike prescription drugs that are made with synthetic chemicals, biotech drugs are derived from substances occurring naturally in the human body or in other living organisms. This is a sweet spot f......

Full article >>> at may be the first major contribution of human embryonic stem cell research. Animal tests generally work well, but tests employing stem cells and biomarkers could dramatically increase accuracy - and weed out dangerous drugs earlier.

That's not to say drugs will ever be cheap so far as consumers are concerned. The search for new medicines is a process that will continue to be costly, mai......

Full article >>>
'"/>

Source:wistechnology.com By Tom Still 12/12/06


Related biology technology :

1. Router Failure and Software Crash UW-Madison Network
2. Primary cells, rat heart endothel
3. Primary cells, rat heart muscle
4. UW tests adult stem cell role in regenerative heart care
5. InvivoSciences receives NIH grant for heart technology
6. FDA approves GEs heart-imaging technology
7. Biotech firm uses live heart tissue in drug screens
8. Aurora team implants Wisconsins first total artificial heart
9. Medical College researchers receive new grants to enhance discovery of heart-protecting anesthetics
10. UW-Madison puts heart and mind into stem cells
11. Technology helps heal heart arrhythmias in children
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/22/2017)... (PRWEB) , ... March 22, 2017 , ... ... up human tissue regeneration from small lab samples to full-size tissues, bones, even ... to establish a vascular system that delivers blood deep into the developing tissue. ...
(Date:3/22/2017)... , March 22, 2017 Good Start Genetics, ... has eclipsed the 130 million covered lives mark through ... of Texas . With newly signed ... continues to enjoy strong payor acceptance based on the ... programs and genetic counseling, its industry-leading customer care and ...
(Date:3/22/2017)... March 22, 2017 The global ... a research report by Transparency Market Research (TMR). The ... Inc., and AbbVie Inc., accounted for a share of ... players in this market are focusing aggressively on mergers, ... which is likely to lead to market consolidation in ...
(Date:3/22/2017)... Mass. , March 22, 2017   Boston ... next-generation cancer therapeutics designed to target cancer stemness pathways, ... Patricia S. Andrews as Chief Executive Officer, effective ... succeed Chiang J. Li , M.D., FACP, who ... ten years ago. Under his leadership, Boston Biomedical has ...
Breaking Biology Technology:
(Date:3/7/2017)... CITY , March 7, 2017   HireVue ... help top global companies identify the best talent, faster, ... as Chief Sales Officer (CSO) and Diana Kucer ... appointments round out a seasoned executive team poised to drive ... beyond, building on a year of record bookings in ...
(Date:3/2/2017)... Summary This report provides all the information ... partnering interests and activities since 2010. Download the ... Deals and Alliance since 2010 report provides an in-depth ... world,s leading life sciences companies. On demand ... of the most up to date deal and company ...
(Date:3/1/2017)... 1, 2017  Aware, Inc. (NASDAQ: AWRE), a leading ... Richard P. Moberg has resigned, effective March 3, ... Financial Officer and Treasurer of Aware citing a desire ... a member of the Board of Directors of Aware. ... Executive Officer and co-President, General Counsel has been named ...
Breaking Biology News(10 mins):